Free Newsletter
Tools speed contaminant detection
Millipore and the newly formed Roka Bioscience say they are jointly developing molecular assays and portable instruments for biopharmaceutical production. Roka is a spinoff of Gen-Probe.
The joint effort is aimed at speeding the detection of microbial contamination so biopharma manufacturers can take corrective actions earlier in the production process, limiting contamination impact. The earlier intervention is expected to reduce downstream processing risks and optimize product yields, according to an announcement.
The work is based on a Millipore and Gen-Probe partnership dating to 2005. It led to the MilliPROBE system, which combines Millipore sample prep methodologies with Gen-Probe nucleic acid technologies for speed and sensitivity in one microbial screening tool. MilliPROBE uses real-time transcription-mediated amplification technology to detect contaminants.
The partners have one assay on the market for Pseudomonas aeruginosa and are developing a second assay for Mycoplasma.
- here's the announcement
Related Articles:
Deal adds drug analysis to Millipore offerings
Millipore expands in Massachusetts
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
